A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial.

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

This study reports DLM's trained with uncertainty estimations, using ran-domly initialized weights and Monte Carlo dropout, to segment tumors from microscopic Hematoxylin and Eosin dye stained ...